Search

Search Constraints

You searched for: Author/Creator Harris, David C H

Search Results

2. Dendritic cell-targeted CD40 DNA vaccine suppresses Th17 and ameliorates progression of experimental autoimmune glomerulonephritis. Issue 4 (27th February 2019)

3. Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activation. Issue 11 (26th December 2018)

4. Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases. (September 2021)

5. Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD). Issue 1 (21st January 2018)

6. Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development. Issue 6 (24th December 2020)

7. The IDEAL trial in Australia and New Zealand: clinical and economic impact. Issue 1 (28th September 2021)